drugset / Trial / NCT01305850
The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a prospective, randomized, placebo controlled, multi-center clinical trial to determine whether aliskiren or aliskiren plus losartan or enalapril plus losartan effects on peritoneal membrane transportation.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-08
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aliskiren | Small molecule | 150 mg | — |
| Comparator | Enalapril | Other / unclassified | 20 mg | — |
| Comparator | Losartan | Other / unclassified | 50 mg | — |
Indications
No indication recorded.